CTR9 and cancer: The new function of CTR9 in regulating PRC2-repressive H3K27me3 domains opens new avenues for understanding the biological functions of CTR9 in development and broad cancer types, and for exploring the possibility of using CTR9 as a biomarker to select cancer patients who are responsive to epigenetic therapies targeting PRC2 complex.